Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii

Histopathology. 2024 Jan;84(2):288-290. doi: 10.1111/his.15053.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Female
  • Humans
  • Mutation
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / genetics
  • Ovarian Neoplasms* / pathology
  • Proto-Oncogene Proteins B-raf / genetics
  • Struma Ovarii* / diagnosis
  • Struma Ovarii* / genetics
  • Struma Ovarii* / pathology
  • Telomerase* / genetics
  • Thyroid Neoplasms* / pathology

Substances

  • Proto-Oncogene Proteins B-raf
  • TERT protein, human
  • Telomerase
  • BRAF protein, human